Ramkumar Mandalam - 22 Jul 2025 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Reporting relationship: Director
Issuer ticker: CYRX
Reported as of: 22 Jul 2025
Net transaction value: -$110,699
SEC form: 4
Accepted by SEC: 24 Jul 2025, 17:00:27 UTC
Prior SEC filing: 26 Jun 2025
Next SEC filing: 12 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Ramkumar Mandalam

Key filing fact

Ramkumar Mandalam filed Form 4 for Cryoport, Inc. (CYRX) on 24 Jul 2025.

Key facts

This page summarizes Ramkumar Mandalam's Form 4 filing for Cryoport, Inc. (CYRX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Jul 2025, 17:00.

Change

Previous filing in this sequence was filed on 26 Jun 2025.
Current net transaction value: -$110,699.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001611439 Primary reporting owner

Mandalam Ramkumar

Relationship: Director
Address: C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD
Signature: /s/ Ramkumar Mandalam
Signature date: 24 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYRX transaction

Common Stock

Options Exercise

Transaction value: $184,200
Shares: +60,000
Change %: +82%
Price: $3.07
Shares after: 133,056
Date: 22 Jul 2025
Ownership: Direct
Footnotes: F1

CYRX transaction

Common Stock

Sale

Transaction value: $294,899
Shares: -40,728
Change %: -31%
Price: $7.24
Shares after: 92,328
Date: 22 Jul 2025
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYRX transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -60,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 22 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $3.07
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on June 10, 2025. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.

Footnote F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $7.49, inclusive.

Footnote F3

1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015.

SEC remarks

With respect to prices reported as weighted average prices in Table I, the reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4.